QLT IN FINAL NEGOTIATIONS FOR PHOTOFRIN U.S. MARKETING PARTNER; PHOTODYNAMIC THERAPY FOR ESOPHAGEAL CANCER TREATMENT GAINS APPROVAL DEC. 27
Executive Summary
Quadra Logic Technologies PhotoTherapeutics is in late-stage negotiations with a potential U.S. marketing partner for its newly-approved photodynamic therapy Photofrin, the company said Dec. 28. The product will be introduced in the first half of 1996 by the new marketing partner, Vancouver-based QLT reported.